Diagnosis Value of Combined Detection of Serum SF, CEA and CRP in Non-Small Cell Lung Cancer

被引:21
作者
Zhou, Jing [1 ]
Diao, Xin [1 ]
Wang, Shengyu [1 ]
Yao, Yang [1 ]
机构
[1] Xian Med Univ, Dept Resp & Crit Care, Affiliated Hosp 1, Xian 710077, Shaanxi, Peoples R China
来源
CANCER MANAGEMENT AND RESEARCH | 2020年 / 12卷
关键词
non-small cell lung cancer; serum ferritin; carcino-embryonic antigen; C-reactive protein; combined detection;
D O I
10.2147/CMAR.S268565
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: The aim of this study was to evaluate the clinical diagnostic value of combined detection of serum ferritin (SF), carcino-embryonic antigen (CEA) and C-reactive protein (CRP) in non-small cell lung cancer (NSCLC). Methods: The study included 70 patients with NSCLC, 50 patients with benign lung disease and 50 healthy subjects. The serum concentrations of SF, CEA and CRP were determined by ELISA. Results: The results showed that the serum levels of SF, CEA and CRP in the NSCLC group were significantly higher than those of the benign lung disease group and the control group. The expression of the above three indexes in the lung cancer group III+IV was higher than that in the I+II group (P<0.05), and the expression of SF, CEA and CRP in the adenocarcinoma group was higher than that in the squamous cell carcinoma group. The difference is statistically significant (P<0.01). When the serum CEA, SF and CRP levels were used alone for diagnosis of NSCLC, CRP had the best diagnostic value. The area under the curve was 0.795. The diagnostic sensitivity and specificity were 81.8% and 66.8%, respectivelyWhen combining these three factors, the area under the curve was 0.890, and the sensitivity and specificity were 80.3% and 82.5%, respectively. The parameters above were also significantly different (all P<0.01). Conclusion: This study indicated that the combined detection of serum SF, CEA and CRP could improve the early diagnostic sensitivity of NSCLC, and may be used as a potential diagnostic method for NSCLC.
引用
收藏
页码:8813 / 8819
页数:7
相关论文
共 50 条
[41]   SPARC expression and prognostic value in non-small cell lung cancer [J].
Huang, Yan ;
Zhang, Jing ;
Zhao, Yuan-Yuan ;
Jiang, Wei ;
Xue, Cong ;
Xu, Fei ;
Zhao, Hong-Yun ;
Zhang, Yang ;
Zhao, Li-Ping ;
Hu, Zhi-Huang ;
Yao, Zhi-Wen ;
Liu, Qian-Yong ;
Zhang, Li .
CHINESE JOURNAL OF CANCER, 2012, 31 (11) :541-548
[42]   A retrospective analysis of serum tumor markers found in non-small cell lung cancer [J].
Hu, Qin ;
Xiao, Ping ;
Li, Junjie ;
Yu, Pijun .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (01) :117-120
[43]   Prognostic and predictive value of HURP in non-small cell lung cancer [J].
Wang, Qi ;
Chen, Yaokun ;
Feng, Hui ;
Zhang, Biyuan ;
Wang, Haiji .
ONCOLOGY REPORTS, 2018, 39 (04) :1682-1692
[44]   Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer [J].
Xu, Chun Hua ;
Chi, Chuan Zhen ;
Zhang, Qian ;
Wang, Yu Chao ;
Wang, Wei ;
Yuan, Qi ;
Zhan, Ping ;
Zhang, Xiu Wei ;
Lin, Yong .
CLINICAL RESPIRATORY JOURNAL, 2018, 12 (10) :2469-2474
[45]   Prognostic value of histology in patients with non-small cell lung cancer [J].
Charloux, A ;
Hedelin, G ;
Dietemann, A ;
Ifoundza, T ;
Roeslin, N ;
Pauli, G ;
Quoix, E .
LUNG CANCER, 1997, 17 (01) :123-134
[46]   Prognostic value of angiogenesis in operable non-small cell lung cancer [J].
Giatromanolaki, A ;
Koukourakis, M ;
OByrne, K ;
Fox, S ;
Whitehouse, R ;
Talbot, DC ;
Harris, AL ;
Gatter, KC .
JOURNAL OF PATHOLOGY, 1996, 179 (01) :80-88
[47]   A preliminary analysis of non-small cell lung cancer biomarkers in serum [J].
Xiao, XY ;
Tang, Y ;
Wei, XP ;
He, DC .
BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2003, 16 (02) :140-148
[48]   A Preliminary Analysis of Non-small Cell Lung Cancer Biomarkers in Serum [J].
XUE-YUAN XIAO# ;
Beijing Tiantan Hospital .
BiomedicalandEnvironmentalSciences, 2003, (02) :140-148
[49]   Clinical value of serum and exhaled breath condensate inflammatory factor IL-11 levels in non-small cell lung cancer: Clinical value of IL-11 in non-small cell lung cancer [J].
Wu, Jinnan ;
Chen, Jinliang ;
Lv, Xuedong ;
Yang, Qichang ;
Yao, Sumei ;
Zhang, Dongmei ;
Chen, Jianrong .
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2021, 36 (02) :64-76
[50]   The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: A meta-analysis [J].
Cui, Chao ;
Sun, Xin ;
Zhang, Jun ;
Han, Dong ;
Gu, Jundong .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (07) :C131-C134